Reported Oct 17, 2018 · Terminated
Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle,…
Takeda Development Center Americas, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Takeda Development Center Americas, Inc. · 1 Takeda Pkwy · Deerfield, IL · 60015-5713
Is this the product you have?
- Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle
- Distributed byTakeda Pharmaceuticals America, Inc, Deerfield, IL 60015
- NDC64764-510-30
- Lot codes and dates
- Lot
- expiry
A26004exp Apr 2020A26443 and A26444exp Sep 2020
- Amount recalled
- 7,248 bottles
Where it was sold
Why it was recalled
Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Takeda Development Center Americas, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.